IBP, Inc. v. Sands

563 N.W.2d 353, 252 Neb. 573, 1997 Neb. LEXIS 133
CourtNebraska Supreme Court
DecidedMay 30, 1997
DocketS-95-968
StatusPublished
Cited by17 cases

This text of 563 N.W.2d 353 (IBP, Inc. v. Sands) is published on Counsel Stack Legal Research, covering Nebraska Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
IBP, Inc. v. Sands, 563 N.W.2d 353, 252 Neb. 573, 1997 Neb. LEXIS 133 (Neb. 1997).

Opinion

McCormack, J.

This is an appeal from the order of the district court which affirmed the decision of the Nebraska Equal Opportunity Commission (NEOC). NEOC found that Lisa Sands was discharged from her job as a chemist with IBP, inc., for narcolepsy and that her discharge was discriminatory. We affirm.

BACKGROUND

Sands began experiencing symptoms of narcolepsy when she was 14 years old. Symptoms of narcolepsy include hypersomnia, sleep paralysis, hypnagogic hallucinations, and cataplexy. Sands’ symptoms included tunnel vision and blackouts. On January 4, 1985, Sands was examined by Dr. Joel Cotton, who diagnosed Sands with narcolepsy and treated her by prescribing Ritalin, a medication used by narcoleptics. The Ritalin diminished her symptoms considerably.

In August 1985, during an office visit with Dr. Cotton, Sands explained that she would not take her Ritalin for 7 to 10 days, then would resume taking the medication when she felt sleepy. She also complained of delusions and hallucinations. Dr. Cotton continued to prescribe Ritalin through 1985.

In October 1986, Dr. Cotton questioned his diagnosis, deciding that Sands was not narcoleptic, but, rather, had a stress disorder, and took her off the Ritalin. From 1986 to approximately 1991, Sands was not taking any Ritalin other than what she had left over from her last prescription from Dr. Cotton. In this period, she finished college and received her degree.

Sands began working as a full-time chemist at IBP’s Dakota City, Nebraska, facility in May 1987. At the beginning of her full-time employment, Sands told her immediate supervisor, Paul Skelton, that she had narcolepsy. Skelton stated that as long as she could function and was comfortable, there would be no problem. Sands did function acceptably from 1986 to 1989 and was promoted to chemist I with supervisory duties in April 1989. As a chemist, Sands was required to run experiments, *575 including the mixing of caustics and acids. She was exposed to perchloric acids, oxidizers, and other “shock sensitive” chemicals which would explode if allowed to dry at a high temperature. There were various carcinogens, irritants, and other reactive, flammable chemicals which presented a danger if not properly handled. Throughout the day, members of the lab personnel would be running experiments simultaneously.

During the time from 1986 to 1991 when Sands was not on Ritalin, there were no reports of any accidents attributable to Sands. In late 1989 and early 1990, Sands’ narcolepsy became more pronounced. Sands appeared to have a problem with attention. She began to carry notes with her to remember how to carry out and complete experiments. She also told coworkers not to be alarmed if she needed to suddenly sit on the floor and did, on one occasion, do so. Once again, however, she functioned acceptably even without taking Ritalin. There was testimony that at some periods of time Sands’ supervisor assigned other supervisors to watch Sands to make sure she did not make any mistakes or hurt herself. There was testimony by coworkers that after 1991 they were concerned about working with her.

In September 1990, Suzanne Shell became senior chemist I. At that time, Sands told her that Sands had problems with hallucinations because she could not take her medication while breast-feeding. Sands also explained to Shell that her predecessor had other supervisors watch over her and make sure nothing bad happened. Shell checked with Sands’ old supervisor, who confirmed this information. Shell then assigned supervisors to monitor Sands.

Sands had work performance evaluations during this period which were above average with regard to the category of “safety.” IBP’s performance rating scale lists a 4.5 as below average, 5 as average, a 5.5 as above average, and a 6 as outstanding. In 1988, Sands’ rating was a 6.3 overall and a 6 for safety. In 1989, Sands rated a 5.9 overall and a 5.8 for safety. In 1990, she rated a 5.3 with a safety rating of 5.5. In 1991, she rated a 4.7 overall and a 5 for safety.

Sands began to experience problems with her 1991 pregnancy; she would not take her Ritalin during pregnancy and was placed on medical leave in April 1991. Due to her inability to *576 take Ritalin during pregnancy and her concern about job security, Sands had a Norplant contraceptive implant to preclude further pregnancies prior to her return to work from her last pregnancy and so advised IBR After Sands returned from medical leave in November 1991, some coworkers, who had talked to Shell, indicated that they had some fears about working with Sands. Shell became concerned about Sands’ ability to work safely and took her concerns to David Soyk, IBP’s medical case manager, and to Bruce George, IBP’s manager of laboratories. Soyk interviewed Sands on October 23, 1991, to determine if she was capable of continuing work and found out at that time from Sands that she had narcolepsy. Sands reported both hallucinations and sleep attacks to Soyk.

Soyk and the others were concerned and decided they needed more information to determine if Sands could work safely, even though she had been doing so for 5 years. With Sands’ permission, Soyk contacted Dr. Cotton initially to determine whether she could continue to work. Dr. Cotton responded that Sands could not continue to work safely in the lab at that time. Dr. Cotton had not seen Sands for almost 5 years. IBP then placed Sands on a medical leave of absence.

On December 27, 1991, Sands went to see Dr. Rodney Dean, a psychiatrist, on a referral from Dr. John Roberts, Sands’ family physician, who was treating her for depression. Dr. Dean diagnosed Sands with narcolepsy and prescribed Ritalin for the condition. In December 1991, Dr. Dean, who was treating Sands at this time, thought that she had a substantial handicap and was unable to perform any task relating to her primary employment. Dr. Dean changed his opinion and medically cleared her to go back to work on January 30, 1992. Dr. Dean pointed out that even when Sands was most symptomatic, she had no incidents of spills or putting herself or other people in danger. Dr. Dean has remained Sands’ treating physician for narcolepsy and examines her on the average of two times per year. Dr. Roberts asked for a second opinion and referred Sands to Dr. James Duggan, who also diagnosed Sands with narcolepsy.

Dr. Dean then referred Sands to Dr. Leonel Herrera, a neurologist, whom Sands saw on April 6, 1992. Dr. Herrera had a difference of opinion with Dr. Dean in that Dr. Herrera said that *577 the symptoms were not typical of narcolepsy. Dr. Dean agrees that they are not typical but, in his opinion, it is still narcolepsy. Dr. Roberts also concurs in the diagnosis of narcolepsy.

Soyk also contacted Drs. Roberts, Herrera, and Dean. Soyk and IBP’s medical consultant, a Dr. John Kuhnlein, toured the lab, spoke with Sands, and examined Sands’ job duties. Dr. Kuhnlein then reviewed Sands’ file, which Soyk said contained medical and physician records. Dr. Kuhnlein was also of the medical opinion that Sands had narcolepsy. Based on this evaluation, Dr. Kuhnlein concluded on December 3, 1992, that Sands could not safely return to work as a chemist.

In January 1992, however, Dr. Dean indicated that Sands had been asymptomatic and that he had cleared her to return to work.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pierce v. Landmark Mgmt. Group
880 N.W.2d 885 (Nebraska Supreme Court, 2016)
Marshall v. EyeCare Specialties
876 N.W.2d 372 (Nebraska Supreme Court, 2016)
Arens v. NEBCO, Inc.
291 Neb. 834 (Nebraska Supreme Court, 2015)
Hartley v. Metropolitan Utilities Dist.
Nebraska Court of Appeals, 2015
Travelers Indemnity Co. v. International Nutrition, Inc.
734 N.W.2d 719 (Nebraska Supreme Court, 2007)
Wolfe v. Becton Dickinson and Co.
662 N.W.2d 599 (Nebraska Supreme Court, 2003)
Stephen C. Orr v. Wal-Mart Stores, Inc.
297 F.3d 720 (Eighth Circuit, 2002)
Fritz v. Wal-Mart Stores, Inc.
158 F. Supp. 2d 991 (D. Nebraska, 2001)
Father Flanagan's Boys' Home v. Agnew
590 N.W.2d 688 (Nebraska Supreme Court, 1999)
FATHER FLANAGAN'S BOYS'HOME v. Agnew
590 N.W.2d 688 (Nebraska Supreme Court, 1999)
WORTMAN BY AND THROUGH WORTMAN v. Unger
578 N.W.2d 413 (Nebraska Supreme Court, 1998)
Norwest Corp. v. State, Dept. of Ins.
571 N.W.2d 628 (Nebraska Supreme Court, 1997)
Vinci v. NEB. DEPT. OF CORR. SERVICES
571 N.W.2d 53 (Nebraska Supreme Court, 1997)
Vinci v. Nebraska Department of Correctional Services
571 N.W.2d 53 (Nebraska Supreme Court, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
563 N.W.2d 353, 252 Neb. 573, 1997 Neb. LEXIS 133, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ibp-inc-v-sands-neb-1997.